文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

ALM液体治疗使不可压迫性出血性休克大鼠模型的交感神经过度活跃转向副交感神经优势

ALM Fluid Therapy Shifts Sympathetic Hyperactivity to Parasympathetic Dominance in the Rat Model of Non-Compressible Hemorrhagic Shock.
PubMed 文献 · Shock · 2022-01-01
一句话结论在大鼠不可压迫性出血性休克模型中,ALM液体治疗组72小时存活4/10,盐水对照组存活1/10,存活与副交感神经优势及心脏泵功能支持相关。

研究在大鼠50%肝切除不可压迫性出血性休克模型中,比较ALM(腺苷、利多卡因、镁)液体治疗与盐水对照对心脏交感/副交感平衡及存活的影响,每组n=10。ALM组4只、盐水组1只存活至72小时。死亡与肾上腺素能(β-1、α-1A)和胆碱能(M2)受体表达下降达97%、心脏炎症、心肌细胞钙负荷及组织病理学改变相关,提示心脏缺血/衰竭。ALM存活者心输出量和每搏量更高,副交感/交感受体表达比值增加30倍,循环脂联素更高。作者认为死亡可能是中枢神经系统调控心脏功能失调所致的「系统衰竭」,存活涉及副交感优势增强以支持心脏泵功能并减少心肌炎症。

要点

  • 大鼠不可压迫性出血性休克模型中,ALM组72小时存活4/10,盐水对照组存活1/10。
  • 死亡与肾上腺素能(β-1、α-1A)和胆碱能(M2)受体表达下降高达97%、心脏炎症、心肌细胞钙负荷及组织病理学改变相关,提示心脏缺血/衰竭。
  • ALM存活者心输出量和每搏量高于盐水对照,副交感/交感受体表达比值增加30倍。
  • ALM存活者循环脂联素高于盐水对照,而盐水组心脏组织脂联素水平反而高于ALM组,受体表达无变化,提示心内合成。
  • 作者认为ALM存活者心脏α-1A肾上腺素能受体升高可能重要,该受体在心功能障碍/衰竭时具有高度保护作用。

适用人群与场景

  • 麻醉成年雄性Sprague-Dawley大鼠,随机分为盐水对照组或ALM治疗组,各n=10。
  • 出血模型为50%肝切除诱导的不可压迫性出血。

处置流程与药物剂量

  • 出血后15分钟静脉推注0.7 mL/kg 3% NaCl±ALM。
  • 出血后60分钟开始输注0.9% NaCl±ALM,持续4小时,速率0.5 mL/kg/h,监测72小时。
  • 动物每6-12小时接受丁丙诺啡镇痛。

研究设计与关键结果

  • 研究类型为大鼠不可压迫性出血性休克模型,盐水对照组与ALM治疗组各n=10。
  • 主要存活结果:ALM组4只、盐水对照组1只存活至72小时。
  • 死亡与肾上腺素能(β-1、α-1A)和胆碱能(M2)受体表达下降高达97%、心脏炎症、心肌细胞钙负荷及组织病理学改变相关,提示心脏缺血/衰竭。
  • ALM存活者心输出量和每搏量高于盐水对照,副交感/交感受体表达比值增加30倍。
  • ALM存活者循环脂联素高于盐水对照;盐水组心脏组织脂联素水平高于ALM组,受体表达无变化,提示心内合成。
  • 作者认为死亡可能是中枢神经系统调控心脏功能失调所致的「系统衰竭」;存活涉及副交感优势增强以支持心脏泵功能并减少心肌炎症。
  • ALM存活者心脏α-1A肾上腺素能受体升高可能重要,该受体在心功能障碍/衰竭时具有高度保护作用。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为ALM液体治疗在不可压迫性出血性休克中可能通过增加副交感优势、支持心脏泵功能并减少心肌炎症而与存活相关。
  • 作者认为ALM存活者心脏α-1A肾上腺素能受体升高可能具有保护意义。
  • 原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Excessive sympathetic outflow following trauma can lead to cardiac dysfunction, inflammation, coagulopathy, and poor outcomes. We previously reported that buprenorphine analgesia decreased survival after hemorrhagic trauma. Our aim is to examine the underlying mechanisms of mortality in a non-compressible hemorrhage rat model resuscitated with saline or adenosine, lidocaine, magnesium (ALM). Anesthetized adult male Sprague-Dawley rats were randomly assigned to Saline control group or ALM therapy group (both n = 10). Hemorrhage was induced by 50% liver resection. After 15 min, 0.7 mL/kg 3% NaCl ± ALM intravenous bolus was administered, and after 60 min, 0.9% NaCl ± ALM was infused for 4 h (0.5 mL/kg/h) with 72 h monitoring. Animals received 6-12-hourly buprenorphine for analgesia. Hemodynamics, heart rate variability, echocardiography, and adiponectin were measured. Cardiac tissue was analyzed for adrenergic/cholinergic receptor expression, inflammation, and histopathology. Four ALM animals and one Saline control survived to 72 h. Mortality was associated with up to 97% decreases in adrenergic (β-1, α-1A) and cholinergic (M2) receptor expression, cardiac inflammation, myocyte Ca2+ loading, and histopathology, indicating heart ischemia/failure. ALM survivors had higher cardiac output and stroke volume, a 30-fold increase in parasympathetic/sympathetic receptor expression ratio, and higher circulating adiponectin compared to Saline controls. Paradoxically, Saline cardiac adiponectin hormone levels were higher than ALM, with no change in receptor expression, indicating intra-cardiac synthesis. Mortality appears to be a "systems failure" associated with CNS dysregulation of cardiac function. Survival involves an increased parasympathetic dominance to support cardiac pump function with reduced myocardial inflammation. Increased cardiac α-1A adrenergic receptor in ALM survivors may be significant, as this receptor is highly protective during heart dysfunction/failure.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Letson HL, Biros E, Morris JL, et al. ALM Fluid Therapy Shifts Sympathetic Hyperactivity to Parasympathetic Dominance in the Rat Model of Non-Compressible Hemorrhagic Shock. Shock. 2022. PMID: 34798632. doi:10.1097/SHK.0000000000001886

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。